Skip to content
Screener

Johnson & Johnson JNJ Q1 2025 earnings

Reported April 15, 2025 · Before market open

Revenue$21.9BBeat by $334.4M
EPS$2.77Beat by $0.19
Revenue estimate$21.6B
EPS estimate$2.58

Next report

Oct 13, 2026 (In 1 week)
Revenue estimate$25.4B
EPS estimate$2.78

Financials

Q1 2025

Income statement

See full
Revenue$21.9B+2.4%
Gross profit$14.5B-2.3%
Operating income$6.2B+4.6%
Net income$11.0B+238%
EPS (diluted)$4.54+239%

Balance sheet

See full
Cash & equivalents$38.5B+51.0%
Total debt$52.3B+55.4%
Total equity$78.1B+11.6%
Total assets$193.67B+12.6%

Cash flow

See full
Operating cash flow$4.2B+14.1%
CapEx$795.0M-1.5%
Free cash flow$3.4B+18.6%

Valuation & ratios

Valuation

as of 03/30/25
See full
Market cap$399.65B+4.9%
Enterprise value$413.43B+6.2%
P/E18.3×+8.4×
P/S4.5×0.0×

Profitability

See full
Gross margin68.3%-0.9pp
Operating margin23.6%-2.2pp
Net margin24.4%-20.5pp
FCF margin22.8%+1.0pp

Returns & leverage

See full
Return on equity29.4%—
Debt / equity0.7×+0.2×
Current ratio1.3×+0.1×

Segments

By product

See full
DARZALEX$3.2B+20.2%
Other$2.8B+813%
STELARA$1.6B-33.7%
GENERAL$1.3B-0.5%
ADVANCED$1.1B-1.3%

By geography

See full
Europe$5.1B-1.0%
Asia-Pacific, Africa$3.3B-2.8%
Western Hemisphere, excluding U.S.$1.2B-2.3%

By segment

See full
Innovative Medicine$13.9B+2.3%
MEDTECH$8.0B+2.5%

FAQ

When did Johnson & Johnson report Q1 2025 earnings?
Johnson & Johnson (JNJ) reported Q1 2025 earnings on April 15, 2025 before market open.
What were Johnson & Johnson's Q1 2025 revenue and EPS?
Johnson & Johnson reported revenue of $21.9B and eps of $2.77 for Q1 2025.
Did Johnson & Johnson beat estimates in Q1 2025?
Revenue beat the consensus estimate of $21.6B by $334.4M. EPS beat the consensus estimate of $2.58 by $0.19.
Where can I find Johnson & Johnson's Q1 2025 SEC filings?
You can read the 8-K earnings release (0000200406-25-000110) and the 10-Q periodic report (0000200406-25-000119) directly on SEC EDGAR. The filing index links above go to sec.gov.